Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1997 Jan;61(1):28–33.

Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines.

K West 1, J Ellis 1
PMCID: PMC1189365  PMID: 9008797

Abstract

The antibody response of cattle to bovine respiratory syncytial virus (BRSV) immunization was investigated using 4 different commercially available mixed vaccines. Forty, 5-6 month old, beef calves, randomly assigned to groups of 10, were vaccinated on day 0 and 21 with 1 of 3 inactivated vaccines, (3 groups), or a modified live virus (MLV) vaccine. BRSV-specific antibody responses were measured prior to vaccination and on day 35 by using an enzyme linked immunosorbent assay (ELISA), virus neutralization assay (VN), a fusion inhibition assay (FI); and responses were also measured for their ability to facilitate antibody dependent, complement mediated cytotoxicity (ADCMC) of BRSV infected cells. Sera from day 35 were, in addition, analyzed by use of an IgG1, IgG2 isotype specific ELISA. All vaccines induced significant increases in BRSV specific IgG antibody as measured by ELISA, but only one inactivated and the MLV vaccine induced significant increases in VN titers. Fusion inhibiting antibody titers were low or undetected in calves vaccinated with the inactivated vaccines. Vaccination with modified live virus induced significantly higher titers of fusion inhibiting antibodies, which are considered to be most highly correlated with protection. The VN to ELISA and FI to ELISA ratio of the calves that received MLV vaccine were significantly greater than the calves receiving the 3 inactivated vaccines. Vaccination with MLV induced the highest IgG2/IgG1 ratio. This difference was small, and only significant relative to 2 of the inactivated vaccine groups, which were not significantly different from each other. The higher proportion of IgG2 isotype in the MLV sera was not associated with lower ADCMC, a function not attributed to this isotype. The VN and FI titers, but not the ELISA value of the sera, were most predictive of ADCMC. The inactivation processes apparently alter epitopes and affect the induction of functional antibodies.

Full text

PDF
28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J., Tsou C., Potter C., Keyserling H. L., Smith T. F., Ananaba G., Bangham C. R. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis. 1994 Nov;170(5):1201–1208. doi: 10.1093/infdis/170.5.1201. [DOI] [PubMed] [Google Scholar]
  2. Belknap E. B., Baker J. C., Patterson J. S., Walker R. D., Haines D. M., Clark E. G. The role of passive immunity in bovine respiratory syncytial virus-infected calves. J Infect Dis. 1991 Mar;163(3):470–476. doi: 10.1093/infdis/163.3.470. [DOI] [PubMed] [Google Scholar]
  3. Brière F., Servet-Delprat C., Bridon J. M., Saint-Remy J. M., Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med. 1994 Feb 1;179(2):757–762. doi: 10.1084/jem.179.2.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Connors M., Collins P. L., Firestone C. Y., Sotnikov A. V., Waitze A., Davis A. R., Hung P. P., Chanock R. M., Murphy B. R. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. Vaccine. 1992;10(7):475–484. doi: 10.1016/0264-410x(92)90397-3. [DOI] [PubMed] [Google Scholar]
  5. Connors M., Giese N. A., Kulkarni A. B., Firestone C. Y., Morse H. C., 3rd, Murphy B. R. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol. 1994 Aug;68(8):5321–5325. doi: 10.1128/jvi.68.8.5321-5325.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connors M., Kulkarni A. B., Firestone C. Y., Holmes K. L., Morse H. C., 3rd, Sotnikov A. V., Murphy B. R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol. 1992 Dec;66(12):7444–7451. doi: 10.1128/jvi.66.12.7444-7451.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Durham P. J., Hassard L. E. Prevalence of antibodies to infectious bovine rhinotracheitis, parainfluenza 3, bovine respiratory syncytial, and bovine viral diarrhea viruses in cattle in Saskatchewan and Alberta. Can Vet J. 1990 Dec;31(12):815–820. [PMC free article] [PubMed] [Google Scholar]
  8. Ellis J. A., Davis W. C., Talens L., Pratt D. L. Clinical and immunologic response of cattle to administration of a vaccine containing modified-live bovine respiratory syncytial virus. J Am Vet Med Assoc. 1990 Feb 15;196(4):583–589. [PubMed] [Google Scholar]
  9. Ellis J. A., Hassard L. E., Morley P. S. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines. J Am Vet Med Assoc. 1995 Feb 1;206(3):354–361. [PubMed] [Google Scholar]
  10. Ellis J. A., Hassard L., Morley P. S. Development and application of a microneutralization ELISA for the detection of antibodies to bovine respiratory syncytial viruses. J Vet Diagn Invest. 1995 Apr;7(2):183–189. doi: 10.1177/104063879500700203. [DOI] [PubMed] [Google Scholar]
  11. Ellis J. A., Russell H., Cavender J., Haven T. R. Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of the specificity and activity of serum antibodies. Vet Immunol Immunopathol. 1992 Oct;34(1-2):35–45. doi: 10.1016/0165-2427(92)90150-o. [DOI] [PubMed] [Google Scholar]
  12. Emery D. L., Rothel J. S., Wood P. R. Influence of antigens and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes. Immunol Cell Biol. 1990 Apr;68(Pt 2):127–136. doi: 10.1038/icb.1990.18. [DOI] [PubMed] [Google Scholar]
  13. Estes D. M., Closser N. M., Allen G. K. IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen. Cell Immunol. 1994 Apr 1;154(1):287–295. doi: 10.1006/cimm.1994.1078. [DOI] [PubMed] [Google Scholar]
  14. Graham B. S., Davis T. H., Tang Y. W., Gruber W. C. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatr Res. 1993 Aug;34(2):167–172. doi: 10.1203/00006450-199308000-00013. [DOI] [PubMed] [Google Scholar]
  15. Graham B. S., Henderson G. S., Tang Y. W., Lu X., Neuzil K. M., Colley D. G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol. 1993 Aug 15;151(4):2032–2040. [PubMed] [Google Scholar]
  16. Groothuis J. R., Simoes E. A., Levin M. J., Hall C. B., Long C. E., Rodriguez W. J., Arrobio J., Meissner H. C., Fulton D. R., Welliver R. C. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18;329(21):1524–1530. doi: 10.1056/NEJM199311183292102. [DOI] [PubMed] [Google Scholar]
  17. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989 May 12;119(2):203–210. doi: 10.1016/0022-1759(89)90397-9. [DOI] [PubMed] [Google Scholar]
  18. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today. 1995 Aug;16(8):374–379. doi: 10.1016/0167-5699(95)80004-2. [DOI] [PubMed] [Google Scholar]
  19. Kimman T. G., Daha M. R., Brinkhof J. M., Westenbrink F. Activation of complement by bovine respiratory syncytial virus-infected cells. Vet Immunol Immunopathol. 1989 Jul;21(3-4):311–325. doi: 10.1016/0165-2427(89)90039-1. [DOI] [PubMed] [Google Scholar]
  20. Kimman T. G., Terpstra G. K., Daha M. R., Westenbrink F. Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: evidence for the involvement of complement and mast cell mediators. Am J Vet Res. 1989 May;50(5):694–700. [PubMed] [Google Scholar]
  21. Kimman T. G., Westenbrink F. Immunity to human and bovine respiratory syncytial virus. Arch Virol. 1990;112(1-2):1–25. doi: 10.1007/BF01348982. [DOI] [PubMed] [Google Scholar]
  22. Kimman T. G., Westenbrink F., Straver P. J., Van Zaane D., Schreuder B. E. Isotype-specific ELISAs for the detection of antibodies to bovine respiratory syncytial virus. Res Vet Sci. 1987 Sep;43(2):180–187. [PubMed] [Google Scholar]
  23. Kimman T. G., Zimmer G. M., Westenbrink F., Mars J., van Leeuwen E. Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease. Vet Rec. 1988 Jul 23;123(4):104–109. doi: 10.1136/vr.123.4.104. [DOI] [PubMed] [Google Scholar]
  24. Kitani A., Strober W. Regulation of C gamma subclass germ-line transcripts in human peripheral blood B cells. J Immunol. 1993 Oct 1;151(7):3478–3488. [PubMed] [Google Scholar]
  25. Malvano R., Boniolo A., Dovis M., Zannino M. ELISA for antibody measurement: aspects related to data expression. J Immunol Methods. 1982;48(1):51–60. doi: 10.1016/0022-1759(82)90209-5. [DOI] [PubMed] [Google Scholar]
  26. Meissner H. C., Fulton D. R., Groothuis J. R., Geggel R. L., Marx G. R., Hemming V. G., Hougen T., Snydman D. R. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother. 1993 Aug;37(8):1655–1658. doi: 10.1128/aac.37.8.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murphy B. R., Prince G. A., Walsh E. E., Kim H. W., Parrott R. H., Hemming V. G., Rodriguez W. J., Chanock R. M. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol. 1986 Aug;24(2):197–202. doi: 10.1128/jcm.24.2.197-202.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Prince G. A., Jenson A. B., Hemming V. G., Murphy B. R., Walsh E. E., Horswood R. L., Chanock R. M. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol. 1986 Mar;57(3):721–728. doi: 10.1128/jvi.57.3.721-728.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rizzo L. V., DeKruyff R. H., Umetsu D. T., Caspi R. R. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur J Immunol. 1995 Mar;25(3):708–716. doi: 10.1002/eji.1830250312. [DOI] [PubMed] [Google Scholar]
  30. Siber G. R., Leombruno D., Leszczynski J., McIver J., Bodkin D., Gonin R., Thompson C. M., Walsh E. E., Piedra P. A., Hemming V. G. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis. 1994 Jun;169(6):1368–1373. doi: 10.1093/infdis/169.6.1368. [DOI] [PubMed] [Google Scholar]
  31. Tang Y. W., Graham B. S. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest. 1994 Nov;94(5):1953–1958. doi: 10.1172/JCI117546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Taylor G., Stott E. J., Bew M., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett J. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology. 1984 May;52(1):137–142. [PMC free article] [PubMed] [Google Scholar]
  33. Taylor G., Stott E. J., Furze J., Ford J., Sopp P. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. J Gen Virol. 1992 Sep;73(Pt 9):2217–2223. doi: 10.1099/0022-1317-73-9-2217. [DOI] [PubMed] [Google Scholar]
  34. Westenbrink F., Kimman T. G., Brinkhof J. M. Analysis of the antibody response to bovine respiratory syncytial virus proteins in calves. J Gen Virol. 1989 Mar;70(Pt 3):591–601. doi: 10.1099/0022-1317-70-3-591. [DOI] [PubMed] [Google Scholar]
  35. Wilkes D. S., Heidler K. M., Niemeier M., Schwenk G. R., Mathur P. N., Breite W. M., Cummings O. W., Weissler J. C. Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection. J Investig Med. 1994 Dec;42(4):652–659. [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES